12:00 AM
 | 
Nov 15, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Adcon-L bioresorbable barrier gel regulatory update

GLIA said the FDA will re-inspect in early December its contract manufacturing firm, European Medical Contract Manufacturing B.V. (Nijmegen,...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >